BioLipids Therapeutics is a health sciences company based in Edmonton, Alberta that uses proprietary processes and intellectual property to refine quantities of gangliosides, a type of bioactive molecule, by enriching it from bovine (cows) milk. These molecules can be used to treat and prevent intestinal diseases and afflictions, such as Irritable Bowel Syndrome caused by Giardiasis, Gluten intolerance, and other conditions.